We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

AI Program Could Aid Decision-Making in Medical Imaging

By HospiMedica International staff writers
Posted on 24 Sep 2018
Image: The Explainable Artificial Intelligence (XAI) program can help with decision-making in various medical fields (Photo courtesy of Raytheon BBN Technologies).
Image: The Explainable Artificial Intelligence (XAI) program can help with decision-making in various medical fields (Photo courtesy of Raytheon BBN Technologies).
Researchers are developing a first of its kind neural network that explains itself and could help with decision-making in the medical field, among others. Raytheon BBN Technologies (Cambridge, MA, USA) is developing the neural network under the Defense Research Project Agency's (DARPA) Explainable Artificial Intelligence program (XAI). The aim of the XAI program is to create a suite of machine learning techniques, which produce more explainable models while maintaining a high level of performance. It also aims to help human users understand, appropriately trust and effectively manage the emerging generation of artificially intelligent partners.

The Explainable Question Answering System (EQUAS) by Raytheon BBN will allow Artificial Intelligence (AI) programs to 'show their work,' increasing the human user's confidence in the machine's suggestions. EQUAS will show users which data mattered most in the AI decision-making process. Using a graphical interface, users can explore the system's recommendations and see why it chose one answer over another. Although the technology is still in its early phases of development, it has the potential to be used for a wide-range of applications. As the system is enhanced, EQUAS will be able to monitor itself and share factors that limit its ability to make reliable recommendations. This self-monitoring capability will help developers refine AI systems, allowing them to inject additional data or change how data is processed.

"A fully developed system like EQUAS could help with decision-making not only in DoD operations, but in a range of other applications like campus security, industrial operations and the medical field," said Bill Ferguson, lead scientist and EQUAS principal investigator at Raytheon BBN. "Say a doctor has an x-ray image of a lung and her AI system says that its cancer. She asks why and the system highlights what it thinks are suspicious shadows, which she had previously disregarded as artifacts of the X-ray process. Now the doctor can make the call – to diagnose, investigate further, or, if she still thinks the system is in error, to let it go."

Related Links:
Raytheon BBN Technologies

Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Radiofrequency Generator
GX1
Medical Examination & Procedure Light
Vega 80

Channels

Critical Care

view channel
Image Credit: iStock

Intraoperative Drug Combination Reduces Kidney Injury in Septic Shock Surgery

Septic shock is a life-threatening response to infection that can cause circulatory failure and organ injury, with global mortality rates reaching 50%. Although emergency surgery can clear the underlying... Read more

Surgical Techniques

view channel
Image: The LUCID prototype, which combines a miniature ultrasound device with a fluid-delivery tube, an osmotic pump and custom electronics. A coin provides a sense of scale. The system is designed to deliver substances directly into brain tissue and uses ultrasound to help them spread. (Photo courtesy of MIT)

Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma

Glioblastoma is an aggressive brain tumor that frequently recurs after surgery. Although surgeons can remove visible tumor tissue, residual cancer cells may remain in surrounding brain tissue and contribute... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more